Company Profile
PainReform Stock Price, News & Analysis
- Ticker:
- PRFX
- Exchange:
- NASDAQ
- Sector:
- Biopharma
- Location:
- Israel and listed in the U
Stock performance
1.10 USD (0.00%)
Close
Last updated: August 6, 2026
1.75M USD
Market cap
Why the stock is moving
As of Aug 6, 2026, PRFX was little changed and closed at $1.10. No new same-company headline was identified in the current news window.
Company overview
Business overview
PainReform is a specialty pharmaceutical company focused on pain management and formulation technology. Its story is built around improving local analgesia through delivery science rather than broad drug discovery.
Geographic Base and Sector Classification
PainReform is headquartered in Israel and listed in the U.S. market. It sits in specialty pharma and pain management.
Business Model Characteristics
The company depends on clinical progress, formulation validation, and commercialization strategy. Investors typically watch data, market access, and capital runway.
Position Within the Biotechnology Landscape
PainReform occupies a niche pain-formulation position within healthcare. The stock is driven by whether its delivery platform can matter in a crowded pain market.
Future catalysts
PainReform’s catalysts are regional-anesthesia products and any update that shows the platform can still gain commercial traction. The company still needs stronger adoption.
Recent news
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What is the current stock price of PainReform (PRFX)?
PainReform (PRFX) most recently closed at 1.10 USD, a 0.00% move versus the previous session.
What is the market cap of PainReform (PRFX)?
PainReform currently has a market capitalization of 1.75M USD on BioPharmSignal.
What does PainReform do?
PainReform is a specialty pharmaceutical company focused on pain management and formulation technology. Its story is built around improving local analgesia through delivery science rather than broad drug discovery.
On which exchange is PRFX stock listed?
PainReform (PRFX) is associated with NASDAQ, Israel and listed in the U, Biopharma.
What is PainReform?
PainReform’s catalysts are regional-anesthesia products and any update that shows the platform can still gain commercial traction.
Which conditions is PainReform targeting with PainReform?
PainReform’s catalysts are regional-anesthesia products and any update that shows the platform can still gain commercial traction.
How does PainReform describe recent progress with PainReform?
PainReform’s catalysts are regional-anesthesia products and any update that shows the platform can still gain commercial traction.
What future catalysts are investors watching for PainReform?
PainReform’s catalysts are regional-anesthesia products and any update that shows the platform can still gain commercial traction. The company still needs stronger adoption.